C4X Discovery Holdings (C4XD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 10.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 21.45
  • 52 Week Low: 8.14
  • Currency: UK Pounds
  • Shares Issued: 252.23m
  • Volume: 1,063,688
  • Market Cap: £25.22m

C4X Discovery CEO to be interim chair of UK Vaccine Taskforce

By Josh White

Date: Tuesday 08 Dec 2020

LONDON (ShareCast) - (Sharecast News) - Drug discovery company C4X Discovery confirmed on Tuesday that its chief executive officer Clive Dix has stepped into the role of interim chair of the UK Vaccine Taskforce.
The taskforce is a group set up by the government to lead the country's efforts to find and manufacture a Covid-19 vaccine.

It would set out arrangements for the long-term leadership of the Vaccine Taskforce shortly.

The AIM-traded firm said Dix was delivering on the company's strategy to advance its portfolio, adding that the appointment would not impact his day-to-day role as CEO.

"The taskforce has worked tirelessly to seek and secure new vaccines for Covid-19," said C4X chairman Eva-Lotta Allan.

"This important work has resulted in the UK being at the forefront of both receiving and developing these critical vaccines and demonstrates the expertise and drive of all those involved.

"As Kate Bingham has reached the end of her agreed tenure as chair, to ensure the smooth continuity of the work carried out by the taskforce, Clive is stepping into the role as chair for an interim period."

Allan said Dix was delivering "strong" leadership at C4X, with a recent fundraise of £15m, which provided a "strong foundation" to continue driving focussed progress across its core portfolio.

"We look forward to providing a more in-depth update at our preliminary results later this month."

At 0845 GMT, shares in C4X Discovery Holdings were down 1.88% at 18.25p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

C4XD Market Data

Currency UK Pounds
Share Price 10.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 21.45
52 Week Low 8.14
Volume 1,063,688
Shares Issued 252.23m
Market Cap £25.22m

C4XD Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.90% above the market average30.90% above the market average30.90% above the market average30.90% above the market average30.90% above the market average
14.81% above the sector average14.81% above the sector average14.81% above the sector average14.81% above the sector average14.81% above the sector average
Price Trend
71.31% below the market average71.31% below the market average71.31% below the market average71.31% below the market average71.31% below the market average
8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average
Income Not Available
Growth
47.09% below the market average47.09% below the market average47.09% below the market average47.09% below the market average47.09% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

C4XD Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:09 7,671 @ 9.41p
15:03 300,000 @ 9.60p
15:00 6,955 @ 9.41p
14:28 100,000 @ 9.41p
14:16 1,000 @ 9.88p

C4XD Key Personnel

CEO Clive Dix
CFO Bradley Hoy

Top of Page